New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
09:19 EDTOLNOlin Corp. upgraded to Neutral from Underperform at Macquarie
Macquarie upgraded Olin to Neutral due to valuation. Price target is $27.
News For OLN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 24, 2015
17:14 EDTOLNOlin Corp. sees earnings improvements in all three business segments in 2015
Subscribe for More Information
07:16 EDTOLNCredit Suisse to hold a conference
Subscribe for More Information
June 16, 2015
08:02 EDTOLNDow Chemical and Olin announce achievement of milestone
Subscribe for More Information
08:01 EDTOLNDow Chemical, Olin announce expiration of HSR waiting period
The Dow Chemical Company (DOW) and Olin Corporation (OLN) announced the achievement of a regulatory milestone in the proposed transaction involving a significant portion of Dow’s chlorine value chain and Olin Corporation, with the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. “This important milestone marks progress toward the close of a seminal transaction maximizing return for both Dow and Olin shareholders and the advancement of Dow’s targeted market participation and portfolio transformation strategies,” said Andrew N. Liveris, Dow’s chairman and CEO.As previously announced on March 27, Dow and Olin entered into a definitive agreement under which Dow will separate its U.S. Gulf Coast Chlor-Alkali and Vinyl, Global Chlorinated Organics and Global Epoxy businesses, and then merge these businesses with Olin in a Reverse Morris Trust transaction. The merger will result in Dow shareholders receiving at least a majority of the shares of Olin, with existing Olin shareholders owning the remaining shares. The transaction is expected to close by the end of the year and is subject to approval by Olin shareholders and completion of customary closing conditions.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use